Literature DB >> 3874713

Developments in pertussis vaccines: memorandum from a WHO meeting.

E Griffiths, J G Kreeftenberg.   

Abstract

Keywords:  Antibodies; Antibody Formation; Bacterial And Fungal Diseases; Biology; Clinical Research; Communicable Diseases; Data Adjustment; Delivery Of Health Care; Diseases; Economic Factors; Epidemics; Evaluation; Evaluation Report; Health; Health Services; Human Volunteers; Immunity; Immunity, Active; Immunization; Immunologic Factors; Infections; International Agencies; Medicine; Organizations; Physiology; Political Factors; Preventive Medicine; Primary Health Care; Research And Development; Research Methodology; Standardization; Technology; Un; Vaccination; Who

Mesh：

Substances：

Year:  1985        PMID： 3874713      PMCID： PMC2536399     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  3 in total

1.  Development of a pertussis component vaccine in Japan.

Authors:  Y Sato; M Kimura; H Fukumi
Journal:  Lancet       Date:  1984-01-21       Impact factor: 79.321

Review 2.  Whooping cough and whooping cough vaccine: the risks and benefits debate.

Authors:  D L Miller; R Alderslade; E M Ross
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

Review 3.  Bordetella pertussis toxins.

Authors:  A C Wardlaw; R Parton
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310
  3 in total
  2 in total

1.  Inhibition of pertussis toxin binding to model receptors by antipeptide antibodies directed at an antigenic domain of the S2 subunit.

Authors:  M A Schmidt; W Schmidt
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

2.  Acellular pertussis vaccine in adults: adverse reactions and immune response.

Authors:  M Granström; M Thorén; M Blennow; M Tiru; Y Sato
Journal:  Eur J Clin Microbiol       Date:  1987-02       Impact factor: 3.267
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.